[Federal Register Volume 69, Number 228 (Monday, November 29, 2004)]
[Notices]
[Page 69376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-26247]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel, Large-Scale Collaborative Project 
Phase 1 Applications.
    Date: December 1, 2004.
    Time: 12 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institute of General Medical Sciences/OSR, 
Natcher Building, 45 Center Drive, Room 3AN12F, Bethesda, MD 20814 
(Telephone Conference Call).
    Contact Person: Helen R. Sunshine, PhD, Chief, Office of 
Scientific Review, National Institute of General Medical Sciences, 
National Institutes of Health, Natcher Building, Room 3AN12F, 
Bethesda, MD 20892, (301) 594-2881, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: November 18, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-26247 Filed 11-26-04; 8:45 am]
BILLING CODE 4140-01-M